Call Us:+1-888-273-6041
Instaappointment Image

Blog

24.Jun, 2017 0

Prostatitis increases risk of prostate cancer – study






A new study has established a strong link between prostatitis, or the inflammation of the prostate gland, and prostate cancer, Renal & Urology News reported on June 29. The research, which involved 1,184 patients with prostate cancer and 1,965 controls, found that men with a history of prostatitis are 83%…

24.Jun, 2017 0

Type-2 diabetes patients at greater risk of heart failure – study






A study has revealed that individuals suffering from type-2 diabetes are at a higher risk of heart failure than those without the condition, Medscape reported on June 8. The study involved the review of data of 1,296 patients who were monitored for an average of 12 years. Researchers found that…

24.Jun, 2017 0

Persistent UTI may point to bladder cancer – study






A recent study suggests persistent urinary tract infection (UTI) could actually be an indicator of bladder cancer, Medscape reported on May 21. A study involving data analysis of 9,326 men and 2,869 women who were diagnosed with either a urinary tract infection (UTI) or hematuria (blood in urine) before being…

24.Jun, 2017 0

Aetna limits its power morcellation coverage due to cancer risk






Aetna, the second largest health insurer in the U.S., has announced that it will curb most of its coverage on hysterectomies involving power morcellators after taking into account the medical device’s risk of spreading undetected uterine cancer, according to CBS News on May 5. Beginning on May 15, the Connecticut-based…

24.Jun, 2017 0

Takeda to pay $2.4 billion to settle Actos lawsuits






Japanese drug company Takeda Pharmaceutical has agreed to pay $2.4 billion to settle lawsuits that claim the company hid knowledge about the diabetes drug Actos‘ risk of causing bladder cancer, The New York Times reported on April 28. The payout aims to settle thousands of bladder cancer claims filed against…

24.Jun, 2017 0

Health insurers want stricter FDA rules on medical devices






American’s Health Insurance Plans, a trade group representing health insurance companies that provide coverage to more than 200 million Americans, is calling for more stringent rules on approving and monitoring medical devices in light of a popular laparoscopic device that has become well-associated with the spread of uterine cancer, The…

24.Jun, 2017 0

Antidepressants may cause sexual side-effects among teens






A study recently published in the journal Pediatrics revealed that selective serotonin reuptake inhibitor (SSRI) antidepressants are linked to sexual side-effects more than half the time among those who use it, including the teens, CBC News reported on Monday, March 23. Co-author Dr. Amir Levine of Columbia University stressed the…

24.Jun, 2017 0

Man wins $2.5M against Risperdal manufacturer






Janssen Pharmaceuticals — a subsidiary of Johnson & Johnson — has been ordered to pay $2.5 million to an autistic man who developed 46DD breasts as a side effect from taking the atypical antipsychotic drug Risperdal, Autism Daily Newscast reported on Tuesday, March 3. Austin Pledger first started taking the…

24.Jun, 2017 0

South Carolina’s Supreme Court cuts Risperdal verdict by over half






A decision by South Carolina’s Supreme Court reduced a $327 million verdict against Risperdal maker Johnson & Johnson (J&J) by more than half, a report by Reuters stated on February 26. According to the report, Justice John Kittredge ordered J&J to pay the state $136 million in light of a…

24.Jun, 2017 0

Yaz lawsuit gets trial date






U.S. District Judge David R. Herndon has set a trial date for one of the lawsuits in the multidistrict litigation he is overseeing regarding health risks posed by the birth control medication, Yaz. Judge Herndon selected a lawsuit filed by Pamela Schuchert, who alleges that she suffered a stroke due…